801 West Biotech Opportunity Series 1
through Aug 13, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Aug 18, 2025 · D | Aug 13, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | — | — | — |
| Reported amount sold | $15,360,000 | $56,885,000 | $41,525,000 |
| Reported investor count | — | 27 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001104659-25-079739 · Later SEC source: 0001104659-26-095672
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $56,885,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- 801 West Capital (Cayman) Fund, Ltd. · CIK 1812278
- 801 WEST CAPITAL FUND, L.P. · CIK 1583997
- Global Access Fund II, LP · CIK 1787830
- Global Access Fund I, LP · CIK 1754401
Form D filings (2)
-
0001104659-26-095672D · Aug 13, 2026 · Pooled Investment FundSold: $56,885,000
Compared with 0001104659-25-079739:
- Reported amount sold: $15,360,000 → $56,885,000
- Reported investor count: Unavailable → 27
-
0001104659-25-079739D · Aug 18, 2025 · Pooled Investment FundSold: $15,360,000